During the past decade, Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria" are "Asthma" (1 trials) and "COVID-19 Pneumonia" (1 trials). Many other conditions were trialed in "Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria" in a lesser frequency.

Most popular intervention types in "Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lebrikizumab" (1 trials) and "Tocilizumab (TCZ)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Fondazione IRCCS Policlinico San Matteo di Pavia; S.S. Fisiopatologia Respiratoria, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".